NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

As for Dr. Furberg he is no longer listed as a member of the SAB and I can't find out any info when it comes to NWBO.

Yes, he no longer is on the SAB of Immunicum.

However, both Curt Furberg and his brother worked with Immunicum from 2008 through to October 2017. In October 2016, Bengt declined re-election to the board.
See attached Bloomberg bios citing this.





Yes... the dendritic cell vaccine for solid tumors that Immunicum is developing is not the same as DCVax. But hey, it's still a dendritic cell vaccine for solid tumors.

My point is that Immunicum is pursuing a similar product that uses dendritic cells that are sourced from healthy donors, and not from the actual tumor patient, and they are hoping to target solid tumors with it. If both DCVax were approved, and Immunicum's product were approved, would they ultimately share the same market?
http://immunicum.se/technology/ilixadencel/

When the brother of the DMC serves on the BOARD OF DIRECTORS of a company that intends to pursue THE SAME SOLID TUMOR PATIENT MARKET as DCVax...
AND...
the DMC Chair himself serves on the Scientific Advisory Board for the same company (and forgets to tell anyone)...

does anyone think it possible that Immunicum would benefit if NWBO, and their DCVax PLATFORM were to fail?

Immunicum's trials are a bit behind L, however, Direct is NOW a bit behind ilixadencel as they are about to complete their P2 trial. Does anyone think they are hoping to make a PLATFORM with their drug when they state they think it has "the potential to become an important part of future immuno-oncology combination treatments?"

As of 2013, Curt's brother Bengt, as a Board member, had 225k stock options and 112.5k underlying shares (preferred that when converted to common, result in 112.5k actual shares) in Immunicum. Curt Furberg, to his credit, had none.

http://www.immunicum.se/wp-content/uploads/2012/10/Annual-Report-120701-130630_Immunicum.pdf

By the end of 2016, Bengt Furberg held only 3,000 shares.
http://immunicum.se/wp-content/uploads/2015/11/Immunicum-AR-2016-Eng-Final-1.pdf

I have no idea why the number of his shares dropped so much.